Results 11 to 20 of about 70,538 (300)

Immunoglobulin replacement therapies in inborn errors of immunity: a review

Frontiers in Pediatrics
Immunoglobulins (Ig) were used as a therapeutic modality for the first time in a patient with X-linked agammaglobulinemia in 1952 by Colonel Ogden Bruton, decades before the molecular mechanisms causing the disease were unraveled.
Archan Sil, Suprit Basu, Vibhu Joshi, Rakesh Kumar Pilania, Sangeetha Siniah, Deepti Suri, Amit Rawat, Surjit Singh   +7 more
doaj   +3 more sources

Managing Primary Immunodeficiency Immunoglobulin Replacement Therapy-Related Adverse Events With Recombinant Human C1 Esterase Inhibitor Prophylaxis: A Case Report. [PDF]

Clin Case Rep
Immunoglobulin replacement therapy (IRT) for primary immunodeficiency reduces infection risk and subsequent complications and can be lifesaving. However, IRT can cause severe systemic adverse events (AEs) that may limit adequate dosing.
Jones DH, Memmott H.
europepmc   +2 more sources

Immunoglobulin Replacement Therapy for Hypogammaglobulinemia in Multiple Myeloma Should Not Be Ignored [PDF]

Turk J Haematol
Zhang Q, Wang Y, Pan W.
europepmc   +2 more sources

An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies

Frontiers in Oncology, 2023
Chronic lymphocytic leukaemia (CLL) is a malignancy of clonally expanded antigen-switched, neoplastic, mature B cells. CLL is characterised by a variable degree of immunosuppression and secondary hypogammaglobulinemia.
Sujoy Khan, David Allsup, David Allsup, Stefano Molica   +3 more
doaj   +1 more source

Immunoglobulin Replacement Therapy in Children [PDF]

Immunology and Allergy Clinics of North America, 2008
The benefit of immunoglobulin (IG) replacement in primary antibody deficiencies is unquestionable. Many of these congenital disorders present early in life and this therapy is often first implemented in the young. This article focuses on the indications of IG replacement in children, with an emphasis on the specific diagnostic problems encountered in ...
Maria, Garcia-Lloret, Sean, McGhee, Talal A, Chatila   +2 more
openaire   +2 more sources

The effect of subcutaneous immunoglobulin replacement therapy on serum IgG levels in patients with primary immunodeficiency

Trends in Pediatrics, 2023
Objective: In a large group of patients with primary immunodeficiency (PID), immunoglobulin replacement therapy is critical for infection control. There are two main methods of immunoglobulin replacement intravenous (IVIG) and subcutaneous (SCIG).
Selime Özen Bölük, Nesrin Gülez, Canan Karkıner, Özgen Soyöz, Figen Çelebi Çelik, Mehmet Şirin Kaya, Idil Akay Hacı, Ilke Taşkırdı, Ömer Akçal, Ferah Genel   +9 more
doaj   +1 more source

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement [PDF]

, 2014
Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients
AA Bousfiha, B Gathmann, B Gathmann, B Piqueras, B Seymour, C Casulo, C Wehr, DF Florescu, E Becerra, E Castigli, ES Resnick, FA Bonilla, G Gunther, H Chapel, H Chapel, H Griffiths, Hilary J. Longhurst, HM Chapel, I De La Torre, I Quinti, J Blore, J Shortt, JA Freeman, JD Edgar, John Dempster, JS Orange, JS Orange, K Warnatz, K Warnatz, L Mouthon, Lorena Lorenzo, M Lucas, M Makatsori, M Yomota, Matthaios Speletas, Matthew Buckland, ME Conley, ME Rose, MJ Boumans, N Ozaras, N Venhoff, NH Yip, P Bright, P McLaughlin, P Wood, R Herriot, S Baris, S Bernatsky, S Molica, Sai S. Duraisingham, Sofia Grigoriadou, SS Duraisingham, T Kawano, U Salzer, W Al-Herz, W Strober   +55 more
core   +9 more sources

Treatment of patients with immunodeficiency: Medication, gene therapy, and transplantation

Jornal de Pediatria, 2021
Objectives: To provide an overview of drug treatment, transplantation, and gene therapy for patients with primary immunodeficiencies. Source of data: Non-systematic review of the literature in the English language carried out at PubMed. Synthesis of data:
Gesmar Rodrigues Silva Segundo, Antonio Condino-Neto   +1 more
doaj   +1 more source

Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study [PDF]

, 2019
We assessed the health-related quality of life (HRQoL) in CVID adults receiving different schedules of immunoglobulin replacement therapy (IgRT) by intravenous (IVIG), subcutaneous (SCIG), and facilitated (fSCIG) preparations.
Agostini, Carlo, Bonanni, Livia, Carrabba, Maria, Cinetto, Francesco, Crescenzi, Ludovica, Fabio, Giovanna, Farrugia, Albert, Milito, Cinzia, Neri, Raffaella, Pecoraro, Antonio, Pulvirenti, Federica, Quinti, Isabella, Spadaro, Giuseppe, Tabolli, Stefano   +13 more
core   +2 more sources

Immunoglobulin replacement therapy for yellow nail syndrome [PDF]

Scandinavian Journal of Immunology, 2018
Immunoglobulin replacement therapy for yellow nail ...
Lo Conte, C., ALLEGRINI, CHIARA, Matucci, A., Bartolucci, M., ROSI, ELIA, Camiciottoli, G., Amendola, M., Pistolesi, M., Bargagli, E.   +8 more
openaire   +5 more sources